SFI Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
SFI Advisors's FBT Position: Q1 2026 in Review
SFI Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 39% in Q1 2026, selling an estimated $1.85M and leaving 14,065 shares worth $2.82M. The position accounts for 2.97% of the portfolio, ranked #14.
SFI Advisors first reported a position in FBT in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.75M in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- SFI Advisors held 14,065 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.82M as of Q1 2026.
- SFI Advisors sold 8,941 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $1.85M.
- First Trust NYSE Arca Biotechnology Index Fund made up 2.97% of SFI Advisors's portfolio in Q1 2026, its #14 holding.
- SFI Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 18 quarters since.
- SFI Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.75M in Q4 2025.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on SFI Advisors's 13F filing for Q1 2026, filed 5 May 2026.